New LiGHT trial data highlights SLT's effectiveness in reducing medication burden for glaucoma and ocular hypertension patients. After 3 years, 60.5% of eyes required no further treatment after switching to SLT. Learn more about these findings. #GlaucomaCare #MedSky conexiant.com/ophthalmolog...
0
0
0
0